Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease. 1998

H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
Department of Psychiatry, Ludwig-Maximilian University Munich, School of Medicine, Germany. hampel@psy.med.uni.muenchen.de

The function of the cytokine interleukin-6 (IL-6) is augmented by soluble IL-6 receptors (sIL-6R). We investigated cerebrospinal fluid sIL-6R concentrations in patients with Alzheimer's disease (AD) compared to age-matched healthy subjects and individuals with at least one first degree relative with AD. We found a statistically significant decrease in sIL-6R levels in the AD group compared to controls. Complete analysis of the IL-6R complex seems crucial to better understand the impact of IL-6 in AD pathophysiology.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
April 1999, Brain research,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
March 1998, Neuroscience letters,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
December 1997, Neuroscience letters,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
January 2024, Alzheimer's & dementia (Amsterdam, Netherlands),
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
November 1999, American heart journal,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
January 2018, Frontiers in neuroscience,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
February 1995, Neuroscience letters,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
January 1996, Clinical and experimental obstetrics & gynecology,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
July 2004, Immunology letters,
H Hampel, and T Sunderland, and H U Kötter, and C Schneider, and S J Teipel, and F Padberg, and R Dukoff, and J Levy, and H J Möller
October 1986, Archives of neurology,
Copied contents to your clipboard!